Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

The ASAP Praises Catheter System which Supports Best Practice Aseptic Technique and Helps Improve Healthcare Worker Safety

Published: Tuesday, October 02, 2012
Last Updated: Tuesday, October 02, 2012
Bookmark and Share
BD NexivaTM Closed IV Catheter System designed to help prevent needlestick injuries and minimise blood exposure.

The Association for Aseptic Practice (ASAP) announced today that it endorses BD Nexiva TM Closed IV Catheter System as a best practice medical device that has been designed to address specific problems in aseptic practice; namely, the risk of catheter-related bloodstream infections (CRBSIs).  This system is the first IV catheter system to be recognised as supporting The ASAP and Aseptic Non-Touch Technique (ANTT®) clinical framework.

The ASAP is committed to improving standards of aseptic technique in clinical practice.  Poor standards of aseptic technique can be a major cause of healthcare-acquired infections (HAIs), such as MRSA and MSSA.  The ASAP oversees the understanding and development of ANTT, a unique, widely recognised and adopted standardised approach to aseptic practice which has been shown to considerably help reduce HCAIs.  BD NexivaTM helps to ensure that best aseptic practice is achieved and clinical procedure is not compromised.

Stephen Rowley, Clinical Director, ANTT UK / USA said, our evaluation identified that “BD Nexiva TM design will help promote asepsis and assists in aseptic technique pre and intra-procedure. The design should also help reduce insertion attempts and improve first-stick success. The blood and needle containment systems were also considered to be innovative ways of protecting health care staff.

Used for peripheral venous access, the all-in-one BD NexivaTM system has BD Instaflash™ technology which is designed to reduce insertion attempts and with its innovative blood-containment system limit healthcare workers’ exposure to blood   This safety-engineered system is also designed to reduce needlestick injury by using passive needle-shielding technology that does not compromise the insertion techniques.

Studies in Europe have estimated that the associated costs of CRBSIs may be hundreds of millions of euros. An important feature incorporated into the BD Nexiva™ Closed IV Catheter System is the BD Q-SyteTM Luer Access Split Septum, which offers a straight and unobstructed fluid path, high flow rates, clear visibility and ease of disinfection.  A split septum needle access system has 64-70% lower CRBSI rates than mechanical halves. By eliminating the complexities of mechanical valves, this split-septum device helps reduce the number of places where bacteria may thrive[iv]. In fact, comparison studies found that patients are three times more likely, on average, to develop a CRBSI with mechanical valves versus a split-septum needle-less access system.

Aseptic practice defines the infection control method and precautions taken during invasive clinical procures to prevent the transfer of micro organisms from the healthcare worker, procedure equipment or the immediate environment to the patient.  It is achieved by ensuring the asepsis of key-parts and key-sites.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

BD Diagnostics MRSA Assay Receives FDA Clearance
Company receives FDA clearance to market the BD MAX™ MRSA XT Assay for use on the fully-automated BD MAX™ System.
Tuesday, January 14, 2014
BD Diagnostics Receive FDA Clearance for StaphSR Assay
BD has received FDA clearance to market the BD MAX™ StaphSR Assay for use on the fully-automated BD MAX™ System.
Tuesday, December 03, 2013
BD announces award to NHS Supply Chain Framework Agreement
New award to the national framework agreement for Microbiology generates interest.
Monday, December 10, 2012
Nationwide Educational Tour Kicks Off on the Future of Molecular Diagnostics
BD Diagnostics convenes experts to address pressing topics for clinical laboratory professionals. Focus will be on the growing role of molecular diagnostics in women’s health, as well as advances in its implementation in the clinical laboratory.
Monday, March 05, 2012
BD Diagnostics Expands Portfolio with Automated Instrumentation Technologies
Company announced the expansion of its microbiology portfolio to include new automated instrumentation technologies that will enable the Company to offer innovative total lab automation solutions to hospitals and laboratories worldwide.
Thursday, February 16, 2012
Scientific News
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Biomedical Imaging at One-Thousandth the Cost
Mathematical modeling enables $100 depth sensor to approximate the measurements of a $100,000 piece of lab equipment.
Improving Outcomes for Lung Cancer and Diabetic Patients
Novel technologies have been developed with support from SBRI Healthcare funding.
New Way of Detecting Cancer
A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analysing a sample equivalent to one drop of blood.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Blood Test Picks Out Prostate Cancer Drug Resistance
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Key Piece of MRSA Vaccine Puzzle
New research funded by the Health Research Board and the Wellcome Trust has pinpointed immune cells that could be targeted by an MRSA vaccine.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos